1. Home
  2. RLMD vs TCBS Comparison

RLMD vs TCBS Comparison

Compare RLMD & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • TCBS
  • Stock Information
  • Founded
  • RLMD 2004
  • TCBS 1934
  • Country
  • RLMD United States
  • TCBS United States
  • Employees
  • RLMD N/A
  • TCBS N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • TCBS Banks
  • Sector
  • RLMD Health Care
  • TCBS Finance
  • Exchange
  • RLMD Nasdaq
  • TCBS Nasdaq
  • Market Cap
  • RLMD 53.4M
  • TCBS 48.7M
  • IPO Year
  • RLMD N/A
  • TCBS N/A
  • Fundamental
  • Price
  • RLMD $1.59
  • TCBS $16.25
  • Analyst Decision
  • RLMD Buy
  • TCBS
  • Analyst Count
  • RLMD 3
  • TCBS 0
  • Target Price
  • RLMD $5.00
  • TCBS N/A
  • AVG Volume (30 Days)
  • RLMD 1.6M
  • TCBS 2.4K
  • Earning Date
  • RLMD 11-06-2025
  • TCBS 11-12-2025
  • Dividend Yield
  • RLMD N/A
  • TCBS 0.98%
  • EPS Growth
  • RLMD N/A
  • TCBS N/A
  • EPS
  • RLMD N/A
  • TCBS 0.80
  • Revenue
  • RLMD N/A
  • TCBS $14,831,000.00
  • Revenue This Year
  • RLMD N/A
  • TCBS N/A
  • Revenue Next Year
  • RLMD N/A
  • TCBS N/A
  • P/E Ratio
  • RLMD N/A
  • TCBS $20.36
  • Revenue Growth
  • RLMD N/A
  • TCBS 51.57
  • 52 Week Low
  • RLMD $0.24
  • TCBS $14.39
  • 52 Week High
  • RLMD $3.98
  • TCBS $19.40
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 74.57
  • TCBS 56.59
  • Support Level
  • RLMD $1.44
  • TCBS $16.10
  • Resistance Level
  • RLMD $1.72
  • TCBS $16.28
  • Average True Range (ATR)
  • RLMD 0.24
  • TCBS 0.10
  • MACD
  • RLMD 0.05
  • TCBS 0.01
  • Stochastic Oscillator
  • RLMD 86.90
  • TCBS 57.48

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About TCBS Texas Community Bancshares Inc.

Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.

Share on Social Networks: